FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620951738> ?p ?o ?g. }

• W2620951738 endingPage "1639" @default.
• W2620951738 startingPage "1628" @default.
• W2620951738 abstract "Golgi phosphoprotein 3 (GOLPH3) is associated with worse prognosis of gliomas, but its role and mechanism in glioma progression remain largely unknown. This study aimed to explore the role and mechanism of GOLPH3 in glioma progression. The expression of GOLPH3 in glioma tissues was detected by quantitative PCR, immunoblotting, and immunohistochemistry. GOLPH3’s effect on glioma progression was examined using cell growth assays and an intracranial glioma model. The effect of GOLPH3 on epidermal growth factor receptor (EGFR) stability, endocytosis, and degradation was examined by immunoblotting and immunofluorescence. The activity of Rab5 was checked by glutathione S-transferase pulldown assay. GOLPH3 was upregulated in gliomas, and its downregulation inhibited glioma cell proliferation both in vitro and in vivo. Furthermore, GOLPH3 depletion dampened EGFR signaling by enhancing EGFR endocytosis, driving EGFR into late endosome and promoting lysosome-mediated degradation. Interestingly, GOLPH3 bound to Rab5 and GOLPH3 downregulation promoted the activation of Rab5. In addition, Rab5 depletion abolished the effect of GOLPH3 on EGFR endocytosis and degradation. Our results imply that GOLPH3 promotes glioma cell proliferation via inhibiting Rab5-mediated endocytosis and degradation of EGFR, thereby activating the phosphatidylinositol-3 kinase (PI3K)–Akt–mammalian target of rapamycin (mTOR) signaling pathway. We find a new mechanism by which GOLPH3 promotes tumor progression through regulating cell surface receptor trafficking. Extensive and intensive understanding of the role of GOLPH3 in glioma progression may provide an opportunity to develop a novel molecular therapeutic target for gliomas." @default.
• W2620951738 created "2017-06-09" @default.
• W2620951738 creator A5002415553 @default.
• W2620951738 creator A5023182786 @default.
• W2620951738 creator A5043098150 @default.
• W2620951738 creator A5049341927 @default.
• W2620951738 creator A5049655034 @default.
• W2620951738 creator A5051219383 @default.
• W2620951738 creator A5051862611 @default.
• W2620951738 creator A5054850370 @default.
• W2620951738 creator A5056101043 @default.
• W2620951738 creator A5056897117 @default.
• W2620951738 creator A5058863593 @default.
• W2620951738 creator A5067065755 @default.
• W2620951738 creator A5072145512 @default.
• W2620951738 creator A5089711982 @default.
• W2620951738 date "2017-06-01" @default.
• W2620951738 modified "2023-10-14" @default.
• W2620951738 title "Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor" @default.
• W2620951738 cites W1221919067 @default.
• W2620951738 cites W1606338704 @default.
• W2620951738 cites W1956553072 @default.
• W2620951738 cites W1964321121 @default.
• W2620951738 cites W1966311581 @default.
• W2620951738 cites W1967084106 @default.
• W2620951738 cites W1974024530 @default.
• W2620951738 cites W1976609069 @default.
• W2620951738 cites W1977303922 @default.
• W2620951738 cites W1987219070 @default.
• W2620951738 cites W1998033835 @default.
• W2620951738 cites W1999365630 @default.
• W2620951738 cites W2003867647 @default.
• W2620951738 cites W2005823843 @default.
• W2620951738 cites W2007797957 @default.
• W2620951738 cites W2011033752 @default.
• W2620951738 cites W2026055716 @default.
• W2620951738 cites W2036044314 @default.
• W2620951738 cites W2048391838 @default.
• W2620951738 cites W2056711495 @default.
• W2620951738 cites W2056881172 @default.
• W2620951738 cites W2061671663 @default.
• W2620951738 cites W2063986127 @default.
• W2620951738 cites W2074851426 @default.
• W2620951738 cites W2095269924 @default.
• W2620951738 cites W2095537445 @default.
• W2620951738 cites W2096885935 @default.
• W2620951738 cites W2109490882 @default.
• W2620951738 cites W2111946930 @default.
• W2620951738 cites W2123359660 @default.
• W2620951738 cites W2133237847 @default.
• W2620951738 cites W2135242557 @default.
• W2620951738 cites W2137794715 @default.
• W2620951738 cites W2140759029 @default.
• W2620951738 cites W2142623337 @default.
• W2620951738 cites W2148163986 @default.
• W2620951738 cites W2152269520 @default.
• W2620951738 cites W2158543265 @default.
• W2620951738 cites W2169663671 @default.
• W2620951738 cites W2343596022 @default.
• W2620951738 cites W2528318606 @default.
• W2620951738 cites W2894683020 @default.
• W2620951738 doi "https://doi.org/10.1093/neuonc/nox104" @default.
• W2620951738 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5716177" @default.
• W2620951738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28575494" @default.
• W2620951738 hasPublicationYear "2017" @default.
• W2620951738 type Work @default.
• W2620951738 sameAs 2620951738 @default.
• W2620951738 citedByCount "40" @default.
• W2620951738 countsByYear W26209517382017 @default.
• W2620951738 countsByYear W26209517382018 @default.
• W2620951738 countsByYear W26209517382019 @default.
• W2620951738 countsByYear W26209517382020 @default.
• W2620951738 countsByYear W26209517382021 @default.
• W2620951738 countsByYear W26209517382022 @default.
• W2620951738 countsByYear W26209517382023 @default.
• W2620951738 crossrefType "journal-article" @default.
• W2620951738 hasAuthorship W2620951738A5002415553 @default.
• W2620951738 hasAuthorship W2620951738A5023182786 @default.
• W2620951738 hasAuthorship W2620951738A5043098150 @default.
• W2620951738 hasAuthorship W2620951738A5049341927 @default.
• W2620951738 hasAuthorship W2620951738A5049655034 @default.
• W2620951738 hasAuthorship W2620951738A5051219383 @default.
• W2620951738 hasAuthorship W2620951738A5051862611 @default.
• W2620951738 hasAuthorship W2620951738A5054850370 @default.
• W2620951738 hasAuthorship W2620951738A5056101043 @default.
• W2620951738 hasAuthorship W2620951738A5056897117 @default.
• W2620951738 hasAuthorship W2620951738A5058863593 @default.
• W2620951738 hasAuthorship W2620951738A5067065755 @default.
• W2620951738 hasAuthorship W2620951738A5072145512 @default.
• W2620951738 hasAuthorship W2620951738A5089711982 @default.
• W2620951738 hasBestOaLocation W26209517381 @default.
• W2620951738 hasConcept C101544691 @default.
• W2620951738 hasConcept C104317684 @default.
• W2620951738 hasConcept C115456853 @default.
• W2620951738 hasConcept C121608353 @default.
• W2620951738 hasConcept C127561419 @default.
• W2620951738 hasConcept C1491633281 @default.
• W2620951738 hasConcept C170493617 @default.

• next